Small randomized controlled trial finds kombucha decreased fasting blood glucose in individuals with type 2 diabetes

FHS
August 3, 2023
10:05 am

A recent study evaluated the anti-hyperglycemic effects of kombucha tea in diabetic adults.

Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 – Biotech Investments

EQS-News: ABIVAX / Key word(s): Conference Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod

January 25, 2024

Infammasomes provide a therapeutic target against human diseases

The structure of inflammasomes and their role in diseases.

January 9, 2024

Overdose Death Notices Plus Guidance Sink Opioid Prescribing

Physicians who received a letter from a medical examiner about a patient’s fatal overdose — along with suggested guidance for future visits for pain —

January 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.